Cite
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.
MLA
Devos, Gaëtan, et al. “Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.” Cancers, vol. 12, no. 8, Aug. 2020. EBSCOhost, https://doi.org/10.3390/cancers12082271.
APA
Devos, G., Berghen, C., Van Eecke, H., Stichele, A. V., Van Poppel, H., Goffin, K., Mai, C., De Wever, L., Albersen, M., Everaerts, W., De Meerleer, G., & Joniau, S. (2020). Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy. Cancers, 12(8). https://doi.org/10.3390/cancers12082271
Chicago
Devos, Gaëtan, Charlien Berghen, Henri Van Eecke, Arthur Vander Stichele, Hendrik Van Poppel, Karolien Goffin, Cindy Mai, et al. 2020. “Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.” Cancers 12 (8). doi:10.3390/cancers12082271.